Selectquote, Inc. (SLQT)
NYSEFinancialsInsurance - BrokersSnapshot 2026-10-29
$0.36-0.47%
Close 2026-10-29 · 1-day change
NYSEFinancialsInsurance - BrokersSnapshot 2026-10-29
Research Workspace
Put SLQT beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Achieve revenue of $1.61B to $1.71B in FY 2026: Revenue: $321.65M.
View ThesisRevenue growth is slowing — up about 6% over the past year and decelerating.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 86% in its worst 12-month stretch.
View RiskSLQT’s sales multiple is far below peers, yet its unprofitable, weak performance leaves revenue execution as the central test. The available earnings history shows a fiscal fourth-quarter loss and a miss, with no revenue growth figure. SLQT trades at 0× sales versus a 3× peer median; the price reflects less growth than we forecast. The thesis is under pressure because FY 2026 revenue of $321.65M trails the $1.61B to $1.71B target. Our model puts the next-quarter miss probability near 41%. Peer multiples imply a price about 78% above where it trades. The thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-29. SLQT is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 4 analysts currently covering SLQT (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare SLQT with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| SLQT Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Insurance Brokers — fair value, gap to price, and forward P/E.
Compare the value case
Put SLQT next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Achieve fiscal 2026 revenue guidance of $1.61B to $1.71B
Shrinking top line impacts revenue guidance for fiscal 2026.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Achieve fiscal 2026 revenue guidance of $1.61B to $1.71B
Earnings call confirms revenue guidance for fiscal 2026.
Threatens: Improve operating cash flow to $25M to $35M for FY 2026
Lower revenue guidance threatens cash flow improvement objective.
Earnings miss indicates potential difficulty in achieving revenue guidance.
